Latest News

EC approves Janssen nasal antidepressant spray

The European Commission (EC) has approved Spravato (esketamine) nasal spray, in combination with a selective serotonin reuptake inhibitor (SSRI) or serotonin and norepinephrine reuptake inhibitor (SNRI) for adults living with treatment-resistant major depressive disorder (TRD), Janssen has announced.

This story continues at EC approves Janssen nasal antidepressant spray

Or just read more coverage at Irish Medical Times

Source link

Related posts

NIH-funded tissue chips that model aspects of the human immune system sent to space


Body composition shown to affect energy spent standing versus sitting


U.S. could see 100,000 new Covid-19 cases per day, Fauci says


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World